A controlled substances diversion prevention program (CSDPP) that aligns with the revised ASHP guidelines is critical to ensure patients are protected from occurrences of drug diversion.
Doug Zurawski, PharmD
Advertisement
Articles by Doug Zurawski, PharmD
The pharmaceutical industry is already seeing the immense benefit of AI and machine-learning technology.
Advertisement
Latest Updated Articles
Enter AI: How Technology is Changing the Pharmaceutical Industry for the BetterPublished: June 26th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Emerging Biomarkers Open New Frontiers in Lung Cancer Therapy
2
Transforming HER2+ Metastatic Breast Cancer Treatment With Targeted ADC Therapy
3
Dato-DXd Doubles Response Rates and Extends Survival in First-Line Metastatic TNBC
4
Targeted α-Particle Radioligand Therapy Shows Promising Activity, Low Toxicity in SSTR2-Positive Neuroendocrine Tumors
5
